Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01940172
Title Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors TetraLogic Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
TetraLogic research site Fresno California 39720 United States Details
TetraLogic Research Site San Luis Obispo California 93401 United States Details
TetraLogic Research Site Fairway Kansas 66205 United States Details
TetraLogic Research Site Boston Massachusetts 02114 United States Details
TetraLogic Research Site Durham North Carolina 27710 United States Details
TetraLogic Research Site Philadelphia Pennsylvania 19107 United States Details
TetraLogic Research Site Philadelphia Pennsylvania 19111 United States Details
TetraLogic Research Site Nashville Tennessee 37203 United States Details
TetraLogic Research Facility Dallas Texas 75201 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field